5,435
Views
110
CrossRef citations to date
0
Altmetric
Research Article

Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats

, , , , , , , , , , & show all
Pages 460-467 | Received 15 Nov 2013, Accepted 20 Jan 2014, Published online: 14 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Sara Safaeian Laein, Iman Katouzian, M. R. Mozafari, Amir Farnudiyan-Habibi, Zahra Akbarbaglu, Mohammad Reza Shadan & Khashayar Sarabandi. (2023) Biological and thermodynamic stabilization of lipid-based delivery systems through natural biopolymers; controlled release and molecular dynamics simulations. Critical Reviews in Food Science and Nutrition 0:0, pages 1-20.
Read now
Fruzsina R. Walter, Ana R. Santa-Maria, Mária Mészáros, Szilvia Veszelka, András Dér & Mária A. Deli. (2021) Surface charge, glycocalyx, and blood-brain barrier function. Tissue Barriers 9:3.
Read now
Saikat Ghosh, Rohan Lalani, Vivek Patel, Subhas Bhowmick & Ambikanandan Misra. (2019) Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities. Expert Opinion on Drug Delivery 16:12, pages 1287-1311.
Read now
Lina Lu, Zongli Li, Yanhua Zuo, Libo Zhao & Bin Liu. (2018) Radioprotective activity of glutathione on cognitive ability in X-ray radiated tumor-bearing mice. Neurological Research 40:9, pages 758-766.
Read now
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Nobuhito Hamano, Shyh-Dar Li, Mahavir Chougule, Sunday A. Shoyele, Umesh Gupta, Ajazuddin & Amit Alexander. (2018) Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opinion on Drug Delivery 15:6, pages 589-617.
Read now
Nila Mary Varghese, Venkatachalam Senthil & Shailendra K. Saxena. (2018) Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements. Journal of Drug Targeting 26:3, pages 195-207.
Read now
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Joon-Soo Kim & Dong-Kug Choi. (2018) Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease. Drug Delivery 25:1, pages 307-320.
Read now
Heba F Salem, Sayed M Ahmed, Ashraf E Hassaballah & Mahmoud M Omar. (2015) Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study. Drug Design, Development and Therapy 9, pages 3705-3727.
Read now

Articles from other publishers (102)

Nguyễn Thị Thanh Nhàn, Tohru Yamada & Kaori H. Yamada. (2023) Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions. International Journal of Molecular Sciences 24:16, pages 12931.
Crossref
Amin Mehrabian, Saba Dadpour, Mohammad Mashreghi, Javad Zarqi, Anis Askarizadeh, Ali Badiee, Leila Arabi, Seyedeh Alia Moosavian & Mahmoud Reza Jaafari. (2023) The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice. IET Nanobiotechnology 17:2, pages 112-124.
Crossref
Surbhi Sharma & Shweta Dang. (2023) Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification. Current Neuropharmacology 21:3, pages 517-535.
Crossref
Hugo Luiz, Jacinta Oliveira Pinho & Maria Manuela Gaspar. (2023) Advancing Medicine with Lipid-Based Nanosystems—The Successful Case of Liposomes. Biomedicines 11:2, pages 435.
Crossref
Sumel Ashique, Obaid Afzal, Sabina Yasmin, Afzal Hussain, Mohammad A. Altamimi, Thomas J Webster & Abdulmalik S.A. Altamimi. (2023) Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective. International Journal of Pharmaceutics 633, pages 122614.
Crossref
Juyoung Seong, Changho Chun, Alec S.T. Smith, Jinmyoung Joo & David L. Mack. 2023. Motor Neurons - New Insights [Working Title]. Motor Neurons - New Insights [Working Title].
Anshupriya Shome. (2023) Applications of Supramolecular Materials in Real World: A Mini Review. Asian Journal of Chemistry 35:2, pages 305-315.
Crossref
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral & Paulo C. Costa. (2023) Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases. Colloids and Surfaces B: Biointerfaces 221, pages 112999.
Crossref
Sofia Parrasia, Ildikò Szabò, Mario Zoratti & Lucia Biasutto. (2022) Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges. Molecular Pharmaceutics 19:11, pages 3700-3729.
Crossref
Joy N. Reginald-Opara, Mingtan Tang, Darren Svirskis, Larry Chamley & Zimei Wu. (2022) The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier. International Journal of Pharmaceutics 626, pages 122152.
Crossref
Shiyong Li, Ye Wang, Miaojin Wu, Muhsin H. Younis, Aeli P. Olson, Todd E. Barnhart, Jonathan W. Engle, Xingen Zhu & Weibo Cai. (2022) Spleen‐Targeted Glabridin‐Loaded Nanoparticles Regulate Polarization of Monocyte/Macrophage ( M o / M φ ) for the Treatment of Cerebral Ischemia‐Reperfusion Injury . Advanced Materials 34:39.
Crossref
Yara Mashal, Hosam Abdelhady & Arun K. Iyer. (2022) Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease. Biomolecules 12:7, pages 1001.
Crossref
Zeinab Jan, Samaneh Mollazadeh, Khalil Abnous, Seyed Mohammad Taghdisi, Abolghasem Danesh, Mohammad Ramezani & Mona Alibolandi. (2022) Targeted Delivery Platforms for the Treatment of Multiple Sclerosis. Molecular Pharmaceutics 19:7, pages 1952-1976.
Crossref
Lina Zhou, Sunitha Kodidela, Sandip Godse, Stacey Thomas-Gooch, Asit Kumar, Babatunde Raji, Kaining Zhi, Harry Kochat & Santosh Kumar. (2022) Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles. Pharmaceuticals 15:3, pages 358.
Crossref
James Brown, Bo Li & Lili Yang. (2022) MAOI Antidepressants: Could They Be a Next-Generation ICB Therapy?. Frontiers in Immunology 13.
Crossref
Alireza Poustforoosh, Mohammad Hadi Nematollahi, Hassan Hashemipour & Abbas Pardakhty. (2022) Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles. Journal of Controlled Release 343, pages 777-797.
Crossref
Mengyang Liu, Yuqing Su, Meng Chen, Jia Wang, Min Liu, Yueying Dai, Chunling Wang, Xiang Luo, Chaoyang Lai, Mingqi Liu, Junqiang Ding, Cong Li, Yawei Hu, Xueying Tang, Xinrong Liu, Yihui Deng & Yanzhi Song. (2022) A preliminary study of the innate immune memory of Kupffer cells induced by PEGylated nanoemulsions. Journal of Controlled Release 343, pages 657-671.
Crossref
Murad Al Gailani, Mengyang Liu & Jingyuan Wen. (2022) Ligands for oral delivery of peptides across the blood-brain-barrier. Acta Materia Medica 1:1.
Crossref
Bibhuti Bhusan Kakoti, Kangkan Deka, Rajashri Bezbaruah & Ngurzampuii Sailo. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 759 773 .
Pallav Namdeo, Jinu Mathew & Ashish Garg. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases 223 242 .
Yang Hu, Pieter J. Gaillard, Jaap Rip & Margareta Hammarlund-Udenaes. 2022. Drug Delivery to the Brain. Drug Delivery to the Brain 501 526 .
Samuel Bonnet, Rana Elfatairi, Florence Franconi, Emilie Roger & Samuel Legeay. (2021) Organic nanoparticle tracking during pharmacokinetic studies. Nanomedicine 16:28, pages 2539-2536.
Crossref
Laís Ribovski, Naomi M. Hamelmann & Jos M. J. Paulusse. (2021) Polymeric Nanoparticles Properties and Brain Delivery. Pharmaceutics 13:12, pages 2045.
Crossref
Shadab Md, Nabil A. Alhakamy, Mohamed A. Alfaleh, Obaid Afzal, Abdulmalik S. A. Altamimi, Ashif Iqubal & Rasheed A. Shaik. (2021) Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches. Journal of Personalized Medicine 11:11, pages 1116.
Crossref
Firda Juhairiyah & Elizabeth C. M. de Lange. (2021) Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential. The AAPS Journal 23:6.
Crossref
Xing Tian, Taojian Fan, Wentian Zhao, Ghulam Abbas, Bo Han, Ke Zhang, Nan Li, Ning Liu, Weiyuan Liang, Hao Huang, Wen Chen, Bing Wang & Zhongjian Xie. (2021) Recent advances in the development of nanomedicines for the treatment of ischemic stroke. Bioactive Materials 6:9, pages 2854-2869.
Crossref
Mohamed HaddadVincent HervéMohamed Raâfet Ben KhedherJean-Michel RabanelCharles Ramassamy. (2021) Glutathione: An Old and Small Molecule with Great Functions and New Applications in the Brain and in Alzheimer's Disease. Antioxidants & Redox Signaling 35:4, pages 270-292.
Crossref
Yung-Chih Kuo, He-Cheng Tsai & Rajendiran Rajesh. (2021) Glutathione Liposomes Carrying Ceftriaxone, FK506, and Nilotinib to Control Overexpressed Dopamine Markers and Apoptotic Factors in Neurons. ACS Biomaterials Science & Engineering 7:7, pages 3242-3255.
Crossref
Anne Mahringer, Elena Puris & Gert Fricker. (2021) Crossing the blood-brain barrier: A review on drug delivery strategies using colloidal carrier systems. Neurochemistry International 147, pages 105017.
Crossref
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker, Salar Hemmati, Yousef Fatahi, Parvin Zakeri-Milani, Muhammad Sarfraz & Hadi Valizadeh. (2021) An update on actively targeted liposomes in advanced drug delivery to glioma. International Journal of Pharmaceutics 602, pages 120645.
Crossref
Mingxiu Tang, Mengjia Yang, Kaiyong He, Ran Li, Xiaojie Chen, Yaowen Wang, Xueqiong Zhang & Tong Qiu. (2021) Glycyrrhetinic acid remodels the tumor microenvironment and synergizes with doxorubicin for breast cancer treatment in a murine model. Nanotechnology 32:18, pages 185702.
Crossref
Nazeer Hussain Khan, Maria Mir, Ebenezeri Erasto Ngowi, Ujala Zafar, Muhammad Mahtab Aslam Khan Khakwani, Saadullah Khattak, Yuan-Kun Zhai, En-She Jiang, Meng Zheng, Shao-Feng Duan, Jian-She Wei, Dong-Dong Wu & Xin-Ying Ji. (2021) Nanomedicine: A Promising Way to Manage Alzheimer’s Disease. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri & Bozena Michniak-Kohn. (2021) Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 13:2, pages 201.
Crossref
Lin Zhou, Runxin Lu, Qijun Liu, Bin Xiao, Li Hai, Li Guo, Yong Wu & Yongxiang Zheng. (2021) Two branched fructose modification improves tumor targeting delivery of liposomes to breast cancer in intro and in vivo. Journal of Drug Delivery Science and Technology 61, pages 102312.
Crossref
M. Masmudi-Martín, L. Zhu, M. Sanchez-Navarro, N. Priego, M. Casanova-Acebes, V. Ruiz-Rodado, E. Giralt & M. Valiente. (2021) Brain metastasis models: What should we aim to achieve better treatments?. Advanced Drug Delivery Reviews 169, pages 79-99.
Crossref
Wen Li, Jianhua QiuXiang-Ling LiSezin Aday, Jingdong Zhang, Grace Conley, Jun Xu, John JosephHaoyue LanRobert Langer, Rebekah Mannix, Jeffrey M. Karp & Nitin Joshi. (2021) BBB pathophysiology–independent delivery of siRNA in traumatic brain injury. Science Advances 7:1.
Crossref
Sudhir H. Ranganath, M. Y. Thanuja, C. Anupama & T. D. Manjunatha. 2021. Immobilization Strategies. Immobilization Strategies 219 269 .
Jessica I. Griffith, Sneha Rathi, Wenqiu Zhang, Wenjuan Zhang, Lester R. Drewes, Jann N. Sarkaria & William F. Elmquist. (2020) Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors. Pharmaceutics 12:12, pages 1205.
Crossref
Mariafrancesca Cascione, Valeria De Matteis, Stefano Leporatti & Rosaria Rinaldi. (2020) The New Frontiers in Neurodegenerative Diseases Treatment: Liposomal-Based Strategies. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Muhammad Bilal, Mahmood Barani, Fakhara Sabir, Abbas Rahdar & George Z. Kyzas. (2020) Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview. NanoImpact 20, pages 100251.
Crossref
Despoina Eleftheriadou, Despoina Kesidou, Francisco Moura, Eric Felli & Wenhui Song. (2020) Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases. Small 16:43.
Crossref
María Sebastián-Morelló, Adrián M. Alambiaga-Caravaca, María Aracely Calatayud-Pascual, Vicent Rodilla, Cristina Balaguer-Fernández, María Miranda & Alicia López-Castellano. (2020) Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases. Pharmaceutics 12:9, pages 861.
Crossref
Koki Ogawa, Naoya Kato & Shigeru Kawakami. (2020) Recent Strategies for Targeted Brain Drug Delivery. Chemical and Pharmaceutical Bulletin 68:7, pages 567-582.
Crossref
Anbu Mozhi, Vishnu Sunil, Wenbo Zhan, Pramila Baban Ghode, Nitish V. Thakor & Chi-Hwa Wang. (2020) Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy. Journal of Controlled Release 323, pages 502-518.
Crossref
Saurabh Mittal, Muhammad U. Ashhar, Farheen F. Qizilbash, Zufika Qamar, Jasjeet K. Narang, Shobhit Kumar, Javed Ali & Sanjula Baboota. (2020) Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological Disorders. Current Pharmaceutical Design 26:19, pages 2291-2305.
Crossref
Jean-Michel Rabanel, Philippe Delbreil, Xavier Banquy, Davide Brambilla & Charles Ramassamy. (2020) Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge. Journal of Controlled Release 322, pages 286-299.
Crossref
Mengyi Huang, Yanchi Pu, Yao Peng, Qiuyi Fu, Li Guo, Yong Wu & Yongxiang Zheng. (2020) Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery. Bioorganic & Medicinal Chemistry Letters 30:12, pages 127151.
Crossref
Mohammad A. Ansari, Ill-Min Chung, Govindasamy Rajakumar, Mohammad A. Alzohairy, Mohammad N. Alomary, Muthu Thiruvengadam, Faheem H. Pottoo & Niyaz Ahmad. (2020) Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review. Current Pharmaceutical Design 26:11, pages 1128-1137.
Crossref
K.R. Gajbhiye, A. Pawar, K.R. Mahadik & V. Gajbhiye. (2020) PEGylated nanocarriers: A promising tool for targeted delivery to the brain. Colloids and Surfaces B: Biointerfaces 187, pages 110770.
Crossref
Zheyu Shen, Ting Liu, Zhen Yang, Zijian Zhou, Wei Tang, Wenpei Fan, Yijing Liu, Jing Mu, Ling Li, Vladimir I. Bregadze, Swadhin K. Mandal, Anna A. Druzina, Zhenni Wei, Xiaozhong Qiu, Aiguo Wu & Xiaoyuan Chen. (2020) Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma. Biomaterials 235, pages 119783.
Crossref
Mahira Zeeshan, Mahwash Mukhtar, Qurat Ul Ain, Salman Khan & Hussain Ali. 2020. Pharmaceutical Formulation Design - Recent Practices. Pharmaceutical Formulation Design - Recent Practices.
Jake Mazur, Kislay Roy, Sarah Shigdar & Jagat R. Kanwar. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents 383 422 .
Nila Mary Varghese & Senthil Venkatachalam. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery 449 472 .
Jinbing Xie, Zheyu Shen, Yasutaka Anraku, Kazunori Kataoka & Xiaoyuan Chen. (2019) Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224, pages 119491.
Crossref
Xiaoqian Niu, Jiejian Chen & Jianqing Gao. (2019) Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances. Asian Journal of Pharmaceutical Sciences 14:5, pages 480-496.
Crossref
Joy N. Reginald-Opara, Darren Svirskis, Simon J. O'Carroll, Sreevalsan Sreebhavan, Justin M. Dean & Zimei Wu. (2019) Optimisation of glutathione conjugation to liposomes quantified with a validated HPLC assay. International Journal of Pharmaceutics 567, pages 118451.
Crossref
Yang Hu, Pieter J. Gaillard, Elizabeth C.M. de Lange & Margareta Hammarlund-Udenaes. (2019) Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?. European Journal of Pharmaceutics and Biopharmaceutics 139, pages 197-204.
Crossref
Luca Bors & Franciska Erdő. (2019) Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery. Scientia Pharmaceutica 87:1, pages 6.
Crossref
Magisetty Obulesu. 2019. Alzheimer's Disease Theranostics. Alzheimer's Disease Theranostics 59 65 .
Magisetty Obulesu. 2019. Alzheimer's Disease Theranostics. Alzheimer's Disease Theranostics 25 31 .
Huile Gao. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System 455 467 .
Naveed Ullah Khan, Tongtong Miao, Xiufeng Ju, Qian Guo & Liang Han. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System 129 158 .
Jinjin Wang, Qianqian Huang & Xing-Jie Liang. 2019. Nanomedicine in Brain Diseases. Nanomedicine in Brain Diseases 59 82 .
Olena O. Kurylenko, Kostyantyn V. Dmytruk & Andriy Sibirny. 2019. Non-conventional Yeasts: from Basic Research to Application. Non-conventional Yeasts: from Basic Research to Application 153 196 .
Sophia Antimisiaris, Spyridon Mourtas & Antonia Marazioti. (2018) Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery. Pharmaceutics 10:4, pages 218.
Crossref
Tang Li, David Cipolla, Thomas Rades & Ben J. Boyd. (2018) Drug nanocrystallisation within liposomes. Journal of Controlled Release 288, pages 96-110.
Crossref
Mária Mészáros, Gergő Porkoláb, Lóránd Kiss, Ana-Maria Pilbat, Zoltán Kóta, Zoltán Kupihár, Albert Kéri, Gábor Galbács, László Siklós, András Tóth, Lívia Fülöp, Mária Csete, Áron Sipos, Petra Hülper, Péter Sipos, Tibor Páli, Gábor Rákhely, Piroska Szabó-Révész, Mária A. Deli & Szilvia Veszelka. (2018) Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier. European Journal of Pharmaceutical Sciences 123, pages 228-240.
Crossref
Bushra Nabi, Saleha Rehman, Saba Khan, Sanjula Baboota & Javed Ali. (2018) Ligand conjugation: An emerging platform for enhanced brain drug delivery. Brain Research Bulletin 142, pages 384-393.
Crossref
Chong Su, Yingze Liu, Yang He & Jingkai Gu. (2018) Analytical methods for investigating in vivo fate of nanoliposomes: A review. Journal of Pharmaceutical Analysis 8:4, pages 219-225.
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2018) Current development of nanocarrier delivery systems for Parkinson's disease pharmacotherapy. Journal of the Taiwan Institute of Chemical Engineers 87, pages 15-25.
Crossref
Xiyou Du, Abdur Rauf Khan, Manfei Fu, Jianbo Ji, Aihua Yu & Guangxi Zhai. (2018) Current development in the formulations of non-injection administration of paclitaxel. International Journal of Pharmaceutics 542:1-2, pages 242-252.
Crossref
Caroline Gaucher, Ariane Boudier, Justine Bonetti, Igor Clarot, Pierre Leroy & Marianne Parent. (2018) Glutathione: Antioxidant Properties Dedicated to Nanotechnologies. Antioxidants 7:5, pages 62.
Crossref
Eleonora VighiDragana TrifunovićPatricia Veiga-CrespoAndreas RentschDorit HoffmannAyse SahabogluTorsten StrasserManoj KulkarniEvelina BertolottiAngelique van den HeuvelTobias Peters, Arie ReijerkerkThomas EulerMarius UeffingFrank SchwedeHans-Gottfried GenieserPieter Gaillard, Valeria Marigo, Per EkströmFrançois Paquet-Durand. (2018) Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration. Proceedings of the National Academy of Sciences 115:13.
Crossref
Sanjay Kumar Singh, Mahendra Kumar Hidau, Shrikant Gautam, Kiran Gupta, Krishna Pal Singh, Shio Kumar Singh & Sanjay Singh. (2018) Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: Pharmacokinetic and teratogenic assessment. International Journal of Biological Macromolecules 108, pages 1092-1100.
Crossref
Milad Ghorbani, Bahareh Bigdeli, Leili Jalili-baleh, Hadi Baharifar, Mohammad Akrami, Sadegh Dehghani, Bahram Goliaei, Amir Amani, Alireza Lotfabadi, Hamid Rashedi, Ismaeil Haririan, Nader Riyahi Alam, Morteza Pirali Hamedani & Mehdi Khoobi. (2018) Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold‑iron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer theranostics. European Journal of Pharmaceutical Sciences 114, pages 175-188.
Crossref
Jake Mazur, Kislay Roy & Jagat R Kanwar. (2018) Recent advances in nanomedicine and survivin targeting in brain cancers. Nanomedicine 13:1, pages 105-137.
Crossref
Christopher D. Spicer, Coline Jumeaux, Bakul Gupta & Molly M. Stevens. (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications. Chemical Society Reviews 47:10, pages 3574-3620.
Crossref
Jean Rabanel, Ghislain Djiokeng-Paka & Charles Ramassamy. 2017. Biomedical Application of Nanoparticles. Biomedical Application of Nanoparticles 277 300 .
Yang Hu, Jaap Rip, Pieter J. Gaillard, Elizabeth C.M. de Lange & Margareta Hammarlund-Udenaes. (2017) The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study. Journal of Pharmaceutical Sciences 106:9, pages 2606-2613.
Crossref
Mukta Agrawal, Ajazuddin, Dulal K. Tripathi, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Spyridon Mourtas, Margareta Hammarlund-Udenaes & Amit Alexander. (2017) Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease. Journal of Controlled Release 260, pages 61-77.
Crossref
Xian-bin Kong, Qiu-yan Tang, Xu-yi Chen, Yue Tu, Shi-zhong Sun & Zhong-lei Sun. (2017) Polyethylene glycol as a promising synthetic material for repair of spinal cord injury. Neural Regeneration Research 12:6, pages 1003.
Crossref
Asya Ozkizilcik, Parker Davidson, Hulusi Turgut, Hari S. Sharma, Aruna Sharma & Z. Ryan Tian. 2017. Drug and Gene Delivery to the Central Nervous System for Neuroprotection. Drug and Gene Delivery to the Central Nervous System for Neuroprotection 33 55 .
Ibrahim Harbi, Bader Aljaeid, Khalid M. El-Say & Ahmed S. Zidan. (2016) Glycosylated Sertraline-Loaded Liposomes for Brain Targeting: QbD Study of Formulation Variabilities and Brain Transport. AAPS PharmSciTech 17:6, pages 1404-1420.
Crossref
Amit Alexander, Ajazuddin, Ravish J. Patel, Swarnlata Saraf & Shailendra Saraf. (2016) Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives. Journal of Controlled Release 241, pages 110-124.
Crossref
Patrícia Figueiredo, Vimalkumar Balasubramanian, Mohammad-Ali Shahbazi, Alexandra Correia, Dalin Wu, Cornelia G. Palivan, Jouni T. Hirvonen & Hélder A. Santos. (2016) Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells. International Journal of Pharmaceutics 511:2, pages 794-803.
Crossref
Mahalingam Rajamanickam Vijayakumar, Kiran Yellappa Vajanthri, Chelladurai Karthikeyan Balavigneswaran, Sanjeev Kumar Mahto, Nira Mishra, Madaswamy S. Muthu & Sanjay Singh. (2016) Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes. Colloids and Surfaces B: Biointerfaces 145, pages 479-491.
Crossref
Panoraia Siafaka, Neslihan Üstündağ Okur, Evangelos Karavas & Dimitrios Bikiaris. (2016) Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses. International Journal of Molecular Sciences 17:9, pages 1440.
Crossref
Huile Gao. (2016) Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharmaceutica Sinica B 6:4, pages 268-286.
Crossref
Mahalingam Rajamanickam Vijayakumar, Ramoji Kosuru, Parameswara Rao Vuddanda, Sanjay Kumar Singh & Sanjay Singh. (2016) Trans resveratrol loaded DSPE PEG 2000 coated liposomes: An evidence for prolonged systemic circulation and passive brain targeting. Journal of Drug Delivery Science and Technology 33, pages 125-135.
Crossref
David Maussang, Jaap Rip, Joan van Kregten, Angelique van den Heuvel, Susanne van der Pol, Burt van der Boom, Arie Reijerkerk, Linda Chen, Marco de Boer, Pieter Gaillard & Helga de Vries. (2016) Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo. Drug Discovery Today: Technologies 20, pages 59-69.
Crossref
Jaap Rip. (2016) Liposome technologies and drug delivery to the CNS. Drug Discovery Today: Technologies 20, pages 53-58.
Crossref
Hans C Helms, N Joan Abbott, Malgorzata Burek, Romeo Cecchelli, Pierre-Olivier Couraud, Maria A Deli, Carola Förster, Hans J Galla, Ignacio A Romero, Eric V Shusta, Matthew J Stebbins, Elodie Vandenhaute, Babette Weksler & Birger Brodin. (2016) In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. Journal of Cerebral Blood Flow & Metabolism 36:5, pages 862-890.
Crossref
Benjamí Oller-Salvia, Macarena Sánchez-Navarro, Ernest Giralt & Meritxell Teixidó. (2016) Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery. Chemical Society Reviews 45:17, pages 4690-4707.
Crossref
Annika Lindqvist, Jaap Rip, Joan van Kregten, Pieter J Gaillard & Margareta Hammarlund-Udenaes. (2015) In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes. Pharmaceutical Research 33:1, pages 177-185.
Crossref
Lisa Sercombe, Tejaswi Veerati, Fatemeh Moheimani, Sherry Y. Wu, Anil K. Sood & Susan Hua. (2015) Advances and Challenges of Liposome Assisted Drug Delivery. Frontiers in Pharmacology 6.
Crossref
Antonietta Vilella, Barbara Ruozi, Daniela Belletti, Francesca Pederzoli, Marianna Galliani, Valentina Semeghini, Flavio Forni, Michele Zoli, Maria Vandelli & Giovanni Tosi. (2015) Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles. Pharmaceutics 7:2, pages 74-89.
Crossref
Maarten Rotman, Mick M. Welling, Anton Bunschoten, Maaike E. de Backer, Jaap Rip, Rob J.A. Nabuurs, Pieter J. Gaillard, Mark A. van Buchem, Silvère M. van der Maarel & Louise van der Weerd. (2015) Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease. Journal of Controlled Release 203, pages 40-50.
Crossref
Huile Gao & Xinguo Jiang. 2015. Blood‐Brain Barrier in Drug Discovery. Blood‐Brain Barrier in Drug Discovery 521 534 .
Matthew C Evans, Pieter J Gaillard, Marco de Boer, Chantal Appeldoorn, Rick Dorland, Nicola R Sibson, Martin R Turner, Daniel C Anthony & Helen B Stolp. (2014) CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis. Acta Neuropathologica Communications 2:1.
Crossref
Julia Georgieva, Dick Hoekstra & Inge Zuhorn. (2014) Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier. Pharmaceutics 6:4, pages 557-583.
Crossref
Xiang Yi, Devika S. Manickam, Anna Brynskikh & Alexander V. Kabanov. (2014) Agile delivery of protein therapeutics to CNS. Journal of Controlled Release 190, pages 637-663.
Crossref
Thomas Birngruber, Reingard Raml, Werner Gladdines, Christina Gatschelhofer, Edgar Gander, Arijit Ghosh, Thomas Kroath, Pieter J. Gaillard, Thomas R. Pieber & Frank Sinner. (2014) Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,®/Doxil®—A Cerebral Open Flow Microperfusion Pilot Study. Journal of Pharmaceutical Sciences 103:7, pages 1945-1948.
Crossref